Elke Jäger

21.6k total citations · 4 hit papers
218 papers, 12.2k citations indexed

About

Elke Jäger is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Elke Jäger has authored 218 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Oncology, 101 papers in Immunology and 66 papers in Molecular Biology. Recurrent topics in Elke Jäger's work include Immunotherapy and Immune Responses (94 papers), T-cell and B-cell Immunology (40 papers) and vaccines and immunoinformatics approaches (39 papers). Elke Jäger is often cited by papers focused on Immunotherapy and Immune Responses (94 papers), T-cell and B-cell Immunology (40 papers) and vaccines and immunoinformatics approaches (39 papers). Elke Jäger collaborates with scholars based in Germany, United States and Switzerland. Elke Jäger's co-authors include Alexander Knuth, Lloyd J. Old, Julia Karbach, Elisabeth Stockert, Michael Arand, Yao‐Tseng Chen, Gerd Ritter, Sacha Gnjatic, Dirk Jäger and Dirk Jäger and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Elke Jäger

205 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Simultaneous Humoral and Cellular Immune Response against Cancer–Testis Antigen NY-ESO-1: Definition of Human Histocompatibility Leukocyte Antigen (HLA)-A2–binding Peptide Epitopes

1998 594 citations Elke Jäger, Yao-Tseng Chen et al. profile →
A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

1998 593 citations Elisabeth Stockert, Elke Jäger et al. profile →
Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

2008 568 citations Salah‐Eddin Al‐Batran, Claudia Pauligk et al. profile →
Anti-CCR4 mAb selectively depletes effector-type FoxP3⁺CD4⁺regulatory T cells, evoking antitumor immune responses in humans

2013 505 citations Julia Karbach, Elke Jäger et al. profile →

Peers

Countries citing papers authored by Elke Jäger

Since Specialization

Citations

This map shows the geographic impact of Elke Jäger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elke Jäger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elke Jäger more than expected).

Fields of papers citing papers by Elke Jäger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elke Jäger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elke Jäger. The network helps show where Elke Jäger may publish in the future.

Co-authorship network of co-authors of Elke Jäger

This figure shows the co-authorship network connecting the top 25 collaborators of Elke Jäger. A scholar is included among the top collaborators of Elke Jäger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elke Jäger. Elke Jäger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multiple infusions of TILs expanded with IL-2/IL-15/IL-21 lead to an improved PK/PD profile and long-term clinical responses in patients with cold tumors 2025 ·Cytotherapy ·Lucas C. M. Arruda, Julia Karbach, (unknown), H. Altmannsberger, (unknown), (unknown), (unknown), Akin Atmaca, Elke Jäger	0
2	An indirect ELISA for the detection of anti-NY-ESO-1 antibodies in cancer patients and for monitoring cancer therapy 2025 ·Molecular Immunology ·Ji Luo, Sanja Milkovska‐Stamenova, Julia Karbach, Elke Jäger, Ralf Hoffmann, (unknown)	0
3	A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial 2020 ·Clinical Cancer Research ·Matthias Kloor, Miriam Reuschenbach, Claudia Pauligk, Julia Karbach, (unknown), Salah‐Eddin Al‐Batran, Mirjam Tariverdian, Elke Jäger, Magnus von Knebel Doeberitz	92
4	Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision Medicine 2019 ·International Journal of Molecular Sciences ·Joana R. Lérias, (unknown), Inês Pires da Silva, (unknown), (unknown), (unknown), Nuno Figueiredo, Carlos Carvalho, Ernest Dodoo, Elke Jäger, Martin Rao, Markus Maeurer	5
5	Long-term Complete Remission Following Radiosurgery and Immunotherapy in a Melanoma Patient with Brain Metastasis: Immunologic Correlates 2014 ·Cancer Immunology Research ·Julia Karbach, Sacha Gnjatic, (unknown), Akin Atmaca, Eckhart Weidmann, (unknown), Claudia Wahle, Helga Bernhard, Alexander Knuth, Elke Jäger	12
6	A randomised multicentre phase II study with cisplatin/docetaxel vs oxaliplatin/docetaxel as first-line therapy in patients with advanced or metastatic non-small cell lung cancer 2013 ·British Journal of Cancer ·Akin Atmaca, S-E. Al-Batran, Dominique Werner, Claudia Pauligk, (unknown), (unknown), H. Bernhard, (unknown), (unknown), (unknown), K Caca, Nicole Prasnikar, Frank Kullmann, Hans‐Günter Derigs, Michael Koenigsmann, (unknown), T. Neuhaus, Elke Jäger	27
7	Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity 2012 ·Clinical Cancer Research ·Julia Karbach, Antje Neumann, Kathrin Brand, Claudia Wahle, Ekkehard Siegel, Markus Maeurer, Erika Ritter, (unknown), Sacha Gnjatic, Lloyd J. Old, Gerd Ritter, Elke Jäger	79
8	Therapeutic Administration of a Synthetic CpG Oligodeoxynucleotide Triggers Formation of Anti-CpG Antibodies 2012 ·Cancer Research ·Julia Karbach, Antje Neumann, Claudia Wahle, Kathrin Brand, Sacha Gnjatic, Elke Jäger	18
9	Trastuzumab plus Chemotherapy in Gastric Cancer Overexpressing HER-2 and EGFR: A Case Report 2011 ·Onkologie ·Salah‐Eddin Al‐Batran, (unknown), (unknown), Elke Jäger	5
10	Efficient In vivo Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naïve Prostate Cancer Patients 2010 ·Clinical Cancer Research ·Julia Karbach, Antje Neumann, Akin Atmaca, Claudia Wahle, Kathrin Brand, Lotta von Boehmer, Alexander Knuth, Armin Bender, Gerd Ritter, Lloyd J. Old, Elke Jäger	63
11	Cancer Vaccine Enhanced, Non–Tumor-Reactive CD8+ T Cells Exhibit a Distinct Molecular Program Associated with “Division Arrest Anergy” 2009 ·Cancer Research ·Marc Beyer, Julia Karbach, Michael R. Mallmann, Thomas Zander, Daniela Eggle, Sabine Claßen, Svenja Debey‐Pascher, Michael Famulok, Elke Jäger, Joachim L. Schultze	12
12	The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors 2006 ·Clinical Cancer Research ·Francesca Di Modugno, Marcella Mottolese, Anna Di Benedetto, Andrea Conidi, Flavia Novelli, Letizia Perracchio, Irene Venturo, Claudio Botti, Elke Jäger, Angela Santoni, Pier Giorgio Natali, Paola Nisticò	74
13	Reduced Incidence of Severe Palmar-Plantar Erythrodysesthesia and Mucositis in a Prospective Multicenter Phase II Trial with Pegylated Liposomal Doxorubicin at 40 mg/m<sup>2</sup> Every 4 Weeks in Previously Treated Patients with Metastatic Breast Cancer 2006 ·Oncology ·Salah‐Eddin Al‐Batran, H.G. Meerpohl, Gϋnter von Minckwitz, Akin Atmaca, Ulrich R. Kleeberg, Nadia Harbeck, (unknown), (unknown), Jalid Sehouli, Alexander Knuth, Elke Jäger	44
14	Quantifying and Imaging NY-ESO-1/LAGE-1-Derived Epitopes on Tumor Cells Using High Affinity T Cell Receptors 2006 ·The Journal of Immunology ·Marco A. Purbhoo, Deborah H. Sutton, Joanna E. Brewer, (unknown), Maxine E. Hill, Tara Mahon, Julia Karbach, Elke Jäger, Brian Cameron, Nikolai M. Lissin, Paresh Vyas, Ji‐Li Chen, Vincenzo Cerundolo, Bent K. Jakobsen	74
15	Vaccine strategies against NY-ESO-1 in cancer patients 2005 ·Elke Jäger	2
16	Cross-Presentation of HLA Class I Epitopes from Exogenous NY-ESO-1 Polypeptides by Nonprofessional APCs 2003 ·The Journal of Immunology ·Sacha Gnjatic, Djordje Atanackovic, Mitsutoshi Matsuo, Elke Jäger, (unknown), Danila Valmori, Yao-Tseng Chen, Gerd Ritter, Alexander Knuth, Lloyd J. Old	49
17	Regression of Cutaneous Tumor Lesions in Patients Intratumorally Injected with a Recombinant Single-chain Antibody-toxin Targeted to ErbB2/HER2 2003 ·Breast Cancer Research and Treatment ·Marc Azémar, S. Djahansouzi, Elke Jäger, Christine Solbach, Mathias Schmidt, Alexander Maurer, K. Mross, Clemens Unger, Gϋnter von Minckwitz, Peter Dall, Bernd Groner, Winfried S. Wels	69
18	Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51 2002 ·PubMed ·Elke Jäger, Julia Karbach, Sacha Gnjatic, Dirk Jäger, Markus Maeurer, Akin Atmaca, Michael Arand, Jonathan Skipper, Elisabeth Stockert, Yao‐Tseng Chen, Lloyd J. Old, Alexander Knuth	28
19	Impact of Antigen Presentation on TCR Modulation and Cytokine Release: Implications for Detection and Sorting of Antigen-Specific CD8+ T Cells Using HLA-A2 Wild-Type or HLA-A2 Mutant Tetrameric Complexes 2002 ·The Journal of Immunology ·Elke Jäger, Russell D. Salter, Chiara Castelli, Hanni Höhn, Kirsten Freitag, Julia Karbach, Claudia Neukirch, Antje Necker, Alexander Knuth, Markus Maeurer	6
20	Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTL 2000 ·The Journal of Immunology ·Ji‐Li Chen, P. Rod Dunbar, Uzi Gileadi, Elke Jäger, Sacha Gnjatic, Yasuhiro Nagata, Elisabeth Stockert, Dennis Panicali, Yao‐Tseng Chen, Alexander Knuth, Lloyd J. Old, Vincenzo Cerundolo	145

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact